HUTCHMED (LON:HCM) Share Price Passes Above 200 Day Moving Average – Time to Sell?

HUTCHMED (China) Limited (LON:HCM) crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 189.29 and traded as high as GBX 201. HUTCHMED shares last traded at GBX 200, with a volume of 21,068 shares traded.

HUTCHMED Stock Performance

The stock has a market capitalization of £1.67 billion, a price-to-earnings ratio of 96.00 and a beta of 0.43. The company’s fifty day simple moving average is GBX 180.93 and its 200 day simple moving average is GBX 189.31. The company has a quick ratio of 2.97, a current ratio of 4.96 and a debt-to-equity ratio of 7.91.

HUTCHMED Company Profile

We are among the first global-focused novel drug discovery companies in China. Over the past two decades, we have established a fully integrated R&D platform with world-class discovery and development capabilities. Since inception, we have focused on bringing cancer drug candidates from in-house discovery to patients around the world, with our first three oncology medicines now approved marketed in China, the first of which is also marketed in the U.S.

We have also developed a profitable commercial platform with deep pan-China market access, which manufactures, markets and distributes our novel oncology products, as well as prescription drugs and consumer health products in China.

HUTCHMED is listed on the Nasdaq Global Select Market, the Stock Exchange of Hong Kong Limited and the London Stock Exchange’s AIM market (Nasdaq/AIM:HCM; HKEX:13).